Back to Search
DAVID TELFORD, M.D.
M.D.
Psychiatry Physician
NPI: 1750307450IndividualAccepts Medicare
Education
NORTHEASTERN OHIO UNIVERSITY COLLEGE OF MEDICINE
Class of 1992
Research & Publications (16)
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
PMID 19592617·Diabetes·2009
7-preclinical
Staphylococcal pyrogenic toxins in infant urine samples: a possible marker of transient bacteraemia.
PMID 19465408·J Clin Pathol·2009
8-other
The effect of Staphylococcus aureus carriage in late pregnancy on antibody levels to staphylococcal toxins in cord blood and breast milk.
PMID 18665847·FEMS Immunol Med Microbiol·2008
8-other
Transient bacteraemia: a possible cause of sudden life threatening events.
PMID 17467191·Med Hypotheses·2007
8-other
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.
PMID 17130282·J Lipid Res·2007
7-preclinical
The legionnaires' outbreak in Barrow-in-Furness, summer 2002.
PMID 16698973·J Epidemiol Community Health·2006
8-other
Effect of carbohydrate intake on half-marathon performance of well-trained runners.
PMID 16521844·Int J Sport Nutr Exerc Metab·2005
2-rct
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
PMID 16427354·Biochim Biophys Acta·2005
7-preclinical
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
PMID 16210564·Arterioscler Thromb Vasc Biol·2005
7-preclinical
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.
PMID 15951028·Trends Pharmacol Sci·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3260 PROVIDENCE DR, TOWER C, SUITE 537
ANCHORAGE, AK 99508 - Phone
- (907) 212-3090
Quick Facts
- NPI
- 1750307450
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 16
Are you this provider?
Claim Your Profile